In This Section

Program: Tuesday, October 20

Please note that this meeting will take place as an in-person event in Atlanta and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the registration page for details.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

Sunday, Oct. 18 Monday, Oct. 19 Wednesday, Oct. 21

Tuesday, October 20

Tuesday, October 20

BREAKFAST/Networking roundtables

8-9 a.m.

Plenary Session 3: Genetic Ancestry (Similarity), Admixture, and Cancer Disparities

9-10:30 a.m.

Session Chairs: Luis G Carvajal-Carmona, University of California Davis, Davis, California and Christopher Flowers, UT MD Anderson Cancer Center, Houston, Texas

  • 9:05 a.m. | Luis G Carvajal-Carmona
  • 9:20 a.m. | Bridging gaps in gastric cancer: Establishing patient-derived models to identify druggable vulnerabilities
    Leslie Cuellar-Vite, University of California Davis, Davis, California
  • 9:35 a.m. | Modeling ancestry-related subtypes of large B-cell lymphoma
    Sanket Shah, Weill Cornell Medicine, New York, New York
  • 9:50 a.m. | Ann-Kathrin Eisfeld, James Cancer Hospital Solove Research Institute, Columbus, Ohio
  • 10:05 a.m. | Panel Discussion and Q&A

break

10:30-11 a.m.

Frontiers and Opportunities Presentation: Spotlight on Hematologic Malignancies and Cancer Disparities

11 a.m.–11:45 a.m.

Session Chair: Christopher Flowers, UT MD Anderson Cancer Center, Houston, Texas

lunch on own

11:45 a.m.-1:15 p.m.

Robert A. Winn Excellence in Clinical Trials: Career Development Award

11:45 a.m.-12:15 p.m.

  • 11:45 a.m.  | Overview of the Robert A. Winn Excellence in Clinical Trials: Career Development Award Program
    Megan Becker, Executive Director, Winn Career Development Awards Program, VCU Massey Comprehensive Cancer Center, Richmond, Virginia
  • 11:50 a.m. | Dionisia M. Quiroga, James Cancer Hospital Solove Research Institute, Columbus, Ohio
  • 11:55 a.m. | Sonikpreet Aulakh, West Virginia University, Morgantown, Virginia
  • 12:00 p.m. | Pamela B. Allen, Emory University, Atlanta, Georgia
  • 12:05 p.m. | Panel Discussion and Q&A

Plenary Session 4: Environment and Cancer in the Era of Big E and Big Data

1:15-2:45 p.m.

Session Chair: Melissa B. Davis, Morehouse School of Medicine, Atlanta, Georgia

  • 1:20 p.m. | Melissa B. Davis, Morehouse School of Medicine, Atlanta, Georgia
  • 1:40 p.m. | Miranda Jones, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • 2 p.m. | Rena Jones, National Institutes of Health, Bethesda, Maryland
  • 2:20 p.m. | Panel Discussion and Q&A

BREAK

2:45-3 p.m.

Concurrent sessions 3 and 4 

3-4 p.m.

Concurrent Session 3: Addressing Pediatric Cancer Health Disparities from a Multifocal Lens

Session Chairs: Philip J. Lupo, Emory University School of Medicine, Atlanta, Georgia and Michael E. Scheurer, Emory University School of Medicine, Atlanta, Georgia

  • 3:05 p.m. | Michael E. Scheurer, Emory University School of Medicine, Atlanta, Georgia
  • 3:20 p.m. | Maria Monica Gramatges, Baylor College of Medicine, Houston, Texas
  • 3:35 p.m. | Puja Umaretiya, UT Southwestern, Dallas, Texas
  • 3:50 p.m. | Panel Discussion and Q&A

Concurrent Session 4: From Barriers to Breakthroughs: Strengthening Cancer Care Delivery in Rural and Underserved Populations

Session Chairs: Rachel Ceballos, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah and Amy Kennedy, National Cancer Institute, Bethesda, Maryland

  • 3:05 p.m. | Meeting smokers at the counter: A community pharmacy model for rural tobacco cessation
    Melissa A. Little, University of Virginia, Charlottesville, Virginia
  • 3:20 p.m. | Research approaches to understand Helicobacter pylori-associated stomach cancer in rural tribal communities
    Dornell Pete, Fred Hutchinson Cancer Center, Seattle, Washington
  • 3:35 p.m. | Mary C. Schroeder, The University of Iowa, Iowa City, Iowa
  • 3:05 p.m. | Panel Discussion and Q&A

Break

4-4:15 p.m.

Educational Sessions 1 and 2

4:15-5:15 p.m.

Educational Session 1: From Description to Intervention: Advancing Methods to Identify Actionable Drivers of Cancer Disparities

Session Chair: Lauren E. McCullough, Emory University, Rollins School of Public Health, Atlanta, Georgia

  • 4:20 p.m. | How to be a well-adjusted cancer disparities researcher
    Jay Kaufman, McGill School of Population and Global Health, Montreal, QC, Canada
  • 4:35 p.m. | Mya Roberson, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • 4:50 p.m. | Scarlett L. Gomez, University of California San Francisco, San Francisco, California
  • 5:05 p.m. | Panel Discussion and Q&A
    Maimah Karmo, Tigerlily Foundation, Stone Ridge, Virginia

Educational Session 2: Models for Cancer Health Disparities Research

Session Chair: Jose Trevino, VCU Massey Comprehensive Cancer Center, Richmond, Virginia

  • 4:20 p.m. | Improving drug response prediction by increasing the genetic diversity of pre-clinical cancer models
    J. Chuck Harrell, VCU Massey Comprehensive Cancer Center, Richmond, Virginia
  • 4:35 p.m. | Nicholas Woods, UNMC Eppley Institute, Fred & Pamela Buffett Cancer Center, Omaha, Nebraska
  • 4:50 p.m. | Herve Tiriac, UCSD Medical Center, San Diego, California
  • 5:05 p.m. | Panel Discussion and Q&A

Break

5:15–5:30 p.m.

Concurrent Sessions 5 and 6

5:30-6:30 p.m.

Concurrent Session 5: Community Outreach and Engagement in Translational Research: The Cancer Health Disparities SPORE Network

Session Chairs: Scarlett L. Gomez, University of California San Francisco, San Francisco, California and Whitney Steward, National Cancer Institute, Bethesda, Maryland

  • 5:35 p.m. | Lorna McNeill, UT MD Anderson Cancer Center, Houston, Texas
  • 5:50 p.m. | Susan T. Vadaparampil, Moffitt Cancer Center, Tampa, Florida
  • 6:05 p.m. | Kellen Polingyumptewa, The Hopi Tribe Department of Health & Human Services, Kykotsmovi, Arizona
  • 6:20 p.m. | Panel Discussion and Q&A
    Additional Panelist:
    Irving Robinson, Patient Advocate, Jacksonville, Florida
    Tatiana Tate, Chemo Divas Foundation, Los Angeles, California
    Stephanie A. Wynn, Patient Advocate, Tampa, Florida

Concurrent Session 6: Advances in Reducing Disparities in Survivorship, Recurrence, and Progression with a Focus on Asian American Populations

Session Chairs: Jessica Chubak, Kaiser Permanente Washington Health Research Institute, Seattle, Washington amd Jennifer Leng, Memorial Sloan Kettering Cancer Center, New York, New York

  • 5:35 p.m. | Developing psycho-oncology interventions for Chinese Americans with limited English proficiency: The role of culture and community
    Florence Lui, Memorial Sloan Kettering Cancer Center, New York, New York
  • 5:50 p.m. | Janet Chu, University of California San Francisco, San Francisco, California
  • 6:05 p.m. | Aasthaa Bansal, University of Toronto, Toronto, ON, Canada
  • 6:20 p.m. | Panel Discussion and Q&A

Poster Spotlight Presentations 3 and 4

6:30-7 p.m.

Poster Spotlight Presentations 3

  • 6:30-6:33 p.m.         Light Activatable Sustained-exposure Ethanol Injection Technology (LASEIT) promotes systemic immune response in a murine model of colorectal cancer
  • Eva S. Landeta Orozco, University of Maryland, College Park, Maryland
  • 6:33-6:36 p.m.         Cancer history and rural residence as determinants of genetic cancer risk testing engagement among U.S. adults
  • Dongyu Zhang, Augusta University, Augusta, Georgia
  • 6:36-6:39 p.m.         Pediatric RISE: Randomized feasibility study of poverty-targeted cash support intervention for pediatric cancer
  • Colleen A. Kelly, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center; Harvard Medical School, Boston, Massachusetts
  • 6:39-6:42 p.m.         Sex-differential TLR7/FRβ biology shapes innate immunotherapy response in multiple myeloma
  • Olasunkanmi S. Omojokun, Purdue University, Lafayette, Indiana
  • 6:42-6:45 p.m.         Sociodemographic patterns of racial disparities in cardiovascular disease mortality after breast cancer diagnosis by estrogen receptor status
  • Xinyi Feng, Rollins School of Public Health, Emory University, Atlanta, Georgia
  • 6:45-6:48 p.m.         Immune profiling reveals distinct ancestry-associated immune surveillance programmes in breast cancer
  • Sheeba Irshad, King’s College London, London, United Kingdom
  • 6:48-6:51 p.m.         Sexual health concerns and confidence among sexual minority cancer survivors: Gender differences in a national survivorship survey
  • Cristobal Calvillo, University of Arkansas for Medical Sciences, Little Rock, Arkansas
  • 6:51-6:54 p.m.         Are disruptions in Medicaid coverage linked to advanced stage diagnosis of common cancers?
  • Parichoy Pal Choudhury, American Cancer Society, Atlanta, Georgia
  • 6:54-6:57 p.m.         Precision MUC1-targeted nanomedicine reprograms oncogenic signaling and overcomes therapeutic resistance in racially diverse triple-negative breast cancer
  • Briana Kinnel, Morehouse School of Medicine, Atlanta, Georgia
  • 6:57-7 p.m.                Inflammatory, immune and proliferative pathways differentiate the tumors of Black and White Women in the Carolina Endometrial Cancer Study
  • Caitlin Witt, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Poster Spotlight Presentations 4

  • 6:30 p.m. | Racial differences in skeletal muscle transcriptomic signatures reveal distinct cachexia pathways and prognostic biomarkers in advanced pancreatic ductal adenocarcinoma
    Praveen Bhoopathi, Virginia Commonwelath Univeristy, Richmond, Virginia
  • 6:33 p.m. | Genetic ancestry and histology shape homologous recombination deficiency signatures in non-small cell lung cancer
    Moses Kamita, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania
  • 6:36 p.m. | Low tumor expression of PSIP1/LEDGF/p75 is more prevalent in prostate cancer patients of African and East Asian descent and associated with improved immunotherapy outcomes possibly via increased pyroptotic vulnerability
    Adelaide V. Makamure, Loma Linda University, Loma Linda, California
  • 6:39 p.m. |  Tumor-educated platelets function as active regulators of prostate cancer in African Americans rather than passive bystanders in the circulatory microenvironment
    Vera Mariani, George Washington University, Washington, District of Columbia
  • 6:42 p.m. | Integrative multi-omics profiling reveals genomic ancestry-associated molecular features of early-onset colorectal cancer
    Francisco G. Carranza, Beckman Research Institute of City of Hope, Duarte, California
  • 6:45 p.m. | Influences of ancestry-associated non-pathogenic germline variants as cancer vulnerabilities
    Nicole Peiris, Dana-Farber Cancer Institute, Boston, Massachusetts
  • 6:48-6:51 p.m.         Race-specific hypermethylation of breast cancer driver genes concentrates in estrogen receptor-negative tumors
  • Bayan M. Toloubadei, Emory University, Atlanta, Georgia
  • 6:51 p.m. | Sex disparities in mutant p53 (R246S) driven liver tumorigenesis
    Hua Lu, Tulane University School of Medicine, New Orleans, Louisiana
  • 6:54 p.m. |  An ADCK4-NUMBL chimeric transcript generates a cell cycle-regulated cytoplasmic protein associated with Black race and poor prognosis in patients with lung adenocarcinoma
    Lauren A. Cardosi, Moffitt Cancer Center, Tampa, Florida
  • 6:57 p.m. |   Disparities in the tumor-immune microenvironment of primary prostate cancer tumors and lymph node metastases at single-cell spatial resolution
    Carlos S. Moreno, Emory University, Atlanta, Georgia

Poster Session c and Reception

7-8:30 p.m.